OGI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Organigram Global Inc (OGI) is not a strong buy at this moment for a beginner investor with a long-term strategy. While the company shows growth in revenue and gross margin, the significant drop in net income and EPS, coupled with neutral trading sentiment and lack of recent positive news catalysts, suggests that the stock does not currently present a compelling entry point. Additionally, technical indicators and proprietary trading signals do not provide a strong buy signal.
The MACD histogram is positive but contracting, RSI is neutral at 46.056, and moving averages are converging, indicating no clear trend. The stock is trading near its support level (S1: 1.383), with resistance levels at 1.499 and 1.616.
Gross margin improved significantly by 324.49% YoY. Analysts have a Buy rating with an increased price target of C$4.
Net income dropped by -186.98% YoY, and EPS fell by -175.00% YoY. Lack of recent news or significant trading trends. No recent congress trading data or influential figure activity.
In Q1 2026, revenue increased to $63.54M (up 48.70% YoY), but net income dropped to $19.97M (-186.98% YoY), and EPS declined to 0.15 (-175.00% YoY). Gross margin improved to 10.4% (up 324.49% YoY).
Analysts maintain a Buy rating with an increased price target of C$4, citing the company's transition to a vertically integrated global cannabis company and its market-leading positions in pre-rolls, concentrates, and milled flower.
